Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
Trade XBI with:
  • Price/Earnings ttm 11.31
  • Annual Dividend & Yield 0.32 (0.24%)
  • Most Recent Dividend 0.040 on 03/22/21
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 27.85%
  • Historical Volatility 24.66%
  • IV Percentile 0%
  • IV Rank 2.09%
  • IV High 44.30% on 02/25/21
  • IV Low 27.50% on 11/25/20
  • Put/Call Vol Ratio 0.72
  • Today's Volume 16,688
  • Volume Avg (30-Day) 39,385
  • Put/Call OI Ratio 1.27
  • Today's Open Interest 570,368
  • Open Int (30-Day) 577,285

Price Performance

See More
Period Period Low Period High Performance
1-Month
119.98 +13.21%
on 05/13/21
136.45 -0.45%
on 06/11/21
+10.73 (+8.58%)
since 05/11/21
3-Month
118.23 +14.89%
on 05/11/21
149.24 -8.98%
on 03/16/21
-11.12 (-7.57%)
since 03/11/21
52-Week
97.15 +39.81%
on 06/12/20
174.79 -22.29%
on 02/09/21
+36.86 (+37.24%)
since 06/11/20

Most Recent Stories

More News
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval

The approval for Biogen's Alzheimer's disease treatment has spread strong optimism, with many investors pulling in capital to this high growth and high beta sector.

BIIB : 396.64 (-4.36%)
LLY : 224.09 (-4.05%)
XBI : 135.83 (-0.19%)
BBC : 51.08 (+0.67%)
SBIO : 49.81 (+0.30%)
PBE : 77.21 (-0.19%)
GNOM : 23.16 (+0.13%)
Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.

SNY : 53.80 (+0.04%)
AZN : 58.77 (-0.12%)
PFE : 40.15 (-1.30%)
MRNA : 218.85 (+0.85%)
IBB : 162.11 (-0.67%)
XBI : 135.83 (-0.19%)
BBH : 198.70 (-1.09%)
FBT : 174.99 (-0.69%)
BTEC : 59.82 (+0.69%)
BNTX : 238.55 (-0.53%)
CVAC : 97.82 (-7.54%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 77.21 (-0.19%)
ALXN : 181.65 (-0.19%)
AMGN : 242.77 (-0.76%)
IBB : 162.11 (-0.67%)
TECH : 443.94 (+1.87%)
XBI : 135.83 (-0.19%)
5 All-Star ETFs & Stocks to Buy on the Dip

As the U.S. economy is gaining momentum, the dips might charge investors to snap up stocks on the cheap, though they remained wary over inflation fears.

MT : 33.18 (+1.81%)
SNP : 53.87 (+1.05%)
TMHC : 27.87 (+1.01%)
SC : 38.41 (+0.95%)
XRT : 96.50 (+1.73%)
KBE : 53.65 (+0.51%)
BCC : 61.91 (+0.26%)
XBI : 135.83 (-0.19%)
VTWV : 150.74 (+1.00%)
SPYD : 42.33 (+0.36%)
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines

The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

JNJ : 164.96 (-1.27%)
AZN : 58.77 (-0.12%)
PFE : 40.15 (-1.30%)
MRNA : 218.85 (+0.85%)
IBB : 162.11 (-0.67%)
XBI : 135.83 (-0.19%)
BBH : 198.70 (-1.09%)
FBT : 174.99 (-0.69%)
BTEC : 59.82 (+0.69%)
How Will Biotech ETFs React to These Q1 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

BIIB : 396.64 (-4.36%)
ALXN : 181.65 (-0.19%)
GILD : 68.77 (-0.75%)
AMGN : 242.77 (-0.76%)
IBB : 162.11 (-0.67%)
XBI : 135.83 (-0.19%)
BBH : 198.70 (-1.09%)
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

JNJ : 164.96 (-1.27%)
AZN : 58.77 (-0.12%)
NVAX : 209.68 (+2.31%)
IBB : 162.11 (-0.67%)
XBI : 135.83 (-0.19%)
BBH : 198.70 (-1.09%)
FBT : 174.99 (-0.69%)
BTEC : 59.82 (+0.69%)
OCGN : 6.34 (-5.23%)
IBRX : 15.19 (+1.88%)
Best Biotech Stocks & ETFs for mRNA, Gene Editing

Here is what you should know about investing in these life changing technologies.

PFE : 40.15 (-1.30%)
MRNA : 218.85 (+0.85%)
TBIO : 21.39 (-1.43%)
IBB : 162.11 (-0.67%)
CNCR : 31.36 (-0.65%)
EDIT : 37.42 (+1.41%)
XBI : 135.83 (-0.19%)
CRSP : 127.00 (+2.66%)
CHNA : 46.12 (-0.24%)
BNTX : 238.55 (-0.53%)
CVAC : 97.82 (-7.54%)
Novavax Vaccine to Get U.S. Approval? ETFs to Benefit

Novavax (NVAX) is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.

JNJ : 164.96 (-1.27%)
AZN : 58.77 (-0.12%)
NVAX : 209.68 (+2.31%)
IBB : 162.11 (-0.67%)
XBI : 135.83 (-0.19%)
BBH : 198.70 (-1.09%)
VIRS : 30.94 (+0.38%)
BUZZ : 25.86 (+0.98%)
GERM : 39.85 (-0.70%)
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

AZN : 58.77 (-0.12%)
PFE : 40.15 (-1.30%)
MRNA : 218.85 (+0.85%)
NVAX : 209.68 (+2.31%)
IBB : 162.11 (-0.67%)
XBI : 135.83 (-0.19%)
BBH : 198.70 (-1.09%)
FBT : 174.99 (-0.69%)
BTEC : 59.82 (+0.69%)
BNTX : 238.55 (-0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 138.85
2nd Resistance Point 137.65
1st Resistance Point 136.74
Last Price 135.83
1st Support Level 134.63
2nd Support Level 133.43
3rd Support Level 132.52

See More

52-Week High 174.79
Fibonacci 61.8% 145.13
Fibonacci 50% 135.97
Last Price 135.83
Fibonacci 38.2% 126.81
52-Week Low 97.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar